Jerry S. Lanchbury - Oct 9, 2021 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role
Chief Scientific Officer
Signature
By: Nathan A. Smith For: Jerry S. Lanchbury
Stock symbol
MYGN
Transactions as of
Oct 9, 2021
Transactions value $
-$333,844
Form type
4
Date filed
10/12/2021, 04:49 PM
Previous filing
Sep 27, 2021
Next filing
Jan 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYGN Common Stock Tax liability -$134K -4.34K -1.58% $30.88 271K Oct 9, 2021 Direct F1
transaction MYGN Common Stock Tax liability -$200K -6.47K -2.39% $30.88 264K Oct 9, 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 8, 2021.
F2 Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock October 8, 2021.